INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer

BACKGROUND: Previous research suggests the therapeutic cancer vaccine L-BLP25 potentially provides a survival benefit in patients with locally advanced unresectable stage III non-small cell lung carcinoma (NSCLC). These promising findings prompted the phase III study, INSPIRE, in patients of East-As...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yi-Long, Park, Keunchil, Soo, Ross A, Sun, Yan, Tyroller, Karin, Wages, David, Ely, Guy, Yang, James Chih-Hsin, Mok, Tony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203100/
https://www.ncbi.nlm.nih.gov/pubmed/21982342
http://dx.doi.org/10.1186/1471-2407-11-430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203100/
https://www.ncbi.nlm.nih.gov/pubmed/21982342
http://dx.doi.org/10.1186/1471-2407-11-430

Ejemplares similares